Current Ratio of Nascent Biotech Inc. from 30 Sep 2015 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nascent Biotech Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2015 to 30 Jun 2024.
  • Nascent Biotech Inc. Current Ratio for the quarter ending 30 Jun 2024 was 77%, a 160% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q2 2024 77% +47% +160% 30 Jun 2024
Q1 2024 63% +33% +112% 31 Mar 2024
Q4 2023 45% +15% +48% 31 Dec 2023
Q3 2023 34% -3.8% -10% 30 Sep 2023
Q2 2023 30% +5.4% +22% 30 Jun 2023
Q1 2023 29% +0.22% +0.75% 31 Mar 2023
Q4 2022 31% -9.6% -24% 31 Dec 2022
Q3 2022 37% +12% +49% 30 Sep 2022
Q2 2022 24% -2.2% -8.5% 30 Jun 2022
Q1 2022 29% +10% +53% 31 Mar 2022
Q4 2021 40% +38% +1385% 31 Dec 2021
Q3 2021 25% +23% +1377% 30 Sep 2021
Q2 2021 26% +26% +14454% 30 Jun 2021
Q1 2021 19% +19% +6232% 31 Mar 2021
Q4 2020 2.7% -2.1% -44% 31 Dec 2020
Q3 2020 1.7% -7.6% -82% 30 Sep 2020
Q2 2020 0.18% -15% -99% 30 Jun 2020
Q1 2020 0.3% -19% -98% 31 Mar 2020
Q4 2019 4.8% -18% -79% 31 Dec 2019
Q3 2019 9.3% -35% -79% 30 Sep 2019
Q2 2019 15% -96% -86% 30 Jun 2019
Q1 2019 19% -132% -88% 31 Mar 2019
Q4 2018 23% -139% -86% 31 Dec 2018
Q3 2018 44% -84% -66% 30 Sep 2018
Q2 2018 111% -14% -11% 30 Jun 2018
Q1 2018 151% +114% +304% 31 Mar 2018
Q4 2017 161% +136% +540% 31 Dec 2017
Q3 2017 128% +110% +607% 30 Sep 2017
Q2 2017 125% +116% +1332% 30 Jun 2017
Q1 2017 37% +30% +385% 31 Mar 2017
Q4 2016 25% +22% +795% 31 Dec 2016
Q3 2016 18% +12% +215% 30 Sep 2016
Q2 2016 8.7% 30 Jun 2016
Q1 2016 7.7% 31 Mar 2016
Q4 2015 2.8% 31 Dec 2015
Q3 2015 5.7% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.